Pharmacovigilance Market Global Growth, Trends, and Forecast -2023

Posted by miky santhosh on February 7th, 2019

Recent Developments

Boehringer Ingelheim is a German-based Pharmaceutical company. The company’s key interests are respiratory diseases, metabolism, and immunology and oncology diseases. The company partnered with AMPATH to scale up knowledge, skills, and training for healthcare providers in Kenya. The company launched the first veterinary vaccines produced in China. Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities

To know more, read @ https://marketdataforecast.com/market-reports/pharmacovigilence-market-7803/

Market Segmentation

Market Data Forecast published a report named Global Pharmacovigilance Market it is currently valued USD 4.66 billion in 2018 and estimated to be growing at a CAGR of 14.2%, to reach USD 9.05 billion by 2023.

Report segmented as:

Clinical Trail Phase:

•         Pre-clinical
•         Phase-I
•         Phase-II
•         Phase-III
•         Phase-IV

Service Provider:

•         In House
•         Contract Outsourcing

Geographical Segmentation:

On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Pharmacovigilance market was dominated by North America followed by Europe. Asia Pacific is expected to grow at the highest CAGR.